Bruce Philip Blackshaw

Bruce Philip Blackshaw

Auto-generated profile, based on publicly available information

Bruce Philip Blackshaw

Plunkett Centre for Ethics, Australian Catholic University, Darlinghurst, New South Wales, Australia

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 July 2025 in Nurse Education in Practice
Verified
Journal Article
Open access
DRDaniel Rodger
Daniel Rodger
SMSebastian Porsdam Mann
Sebastian Porsdam Mann
BEBrian Earp
Brian Earp
JSJulian Savulescu
Julian Savulescu
CBChristopher Bobier
Christopher Bobier
BBBruce P. Blackshaw
Bruce P. Blackshaw
To examine the challenges and opportunities presented by generative artificial intelligence in healthcare education and explore how it can be used ethically to enhance rather than compromise future healthcare workforce competence. Generative artificial intelligence is fundamentally changing healthcare education, yet many universities and healthcare educators have failed to keep pace with its rapid development. A discussion paper. Discussion and analysis of the challenges and opportunities presented by students' increasing use of generative artificial intelligence in healthcare education, with particular focus on assessment approaches, critical thinking development and artificial intelligence literacy. Students' widespread use of generative artificial intelligence threatens assessment integrity and may inhibit critical thinking, problem-solving skills and knowledge acquisition. Without adequate artificial intelligence literacy there is a risk of eroding future healthcare workforce competence and compromising patient safety and professional integrity. While generative artificial intelligence presents significant challenges to healthcare education, it offers great promise if used carefully with awareness of its limitations. The development of artificial intelligence literacy is crucial for maintaining professional standards and ensuring patient safety and mitigating its potentially negative impact on the formation of critical thinking skills.

10 June 2021 in Journal of Medical Ethics
Verified
Journal Article
Open access
PDF file
BBBruce Philip Blackshaw
Bruce Philip Blackshaw
DRDaniel Rodger
Daniel Rodger
The 14-day rule restricts the culturing of human embryos in vitro for the purposes of scientific research for no longer than 14 days. Since researchers recently developed the capability to exceed the 14-day limit, pressure to modify the rule has started to build. Sophia McCully argues that the limit should be extended to 28 days, listing numerous potential benefits of doing so. We contend that McCully has not engaged with the main reasons why the Warnock Committee set such a limit, and these still remain valid. As a result, her case for an extension of the 14-day rule is not persuasive.

20 October 2018 in Bioethics
Verified
Journal Article
Closed access
PDF file
BBBruce P. Blackshaw
Bruce P. Blackshaw
DRDaniel Rodger
Daniel Rodger

18 February 2019 in BMC Medical Ethics
Verified
Journal Article
Open access
PDF file
DRDaniel Rodger
Daniel Rodger
BBBruce P. Blackshaw
Bruce P. Blackshaw
Animal-derived constituents are frequently used in anaesthesia and surgery, and patients are seldom informed of this. This is problematic for a growing minority of patients who may have religious or secular concerns about their use in their care. It is not currently common practice to inform patients about the use of animal-derived constituents, yet what little empirical data does exist indicates that many patients want the opportunity to give their informed consent. First we review the nature and scale of the problem by looking at the groups who may have concerns about the use of animal-derived constituents in their care. We then summarise some of the products used in anaesthesia and surgery that can contain such constituents, such as anaesthetic drugs, surgical implants and dressings. Finally, we explore the problem of animal-derived constituents and consent using Beauchamp and Childress’ four principles approach, examining issues of autonomy, beneficence, nonmaleficence and justice. Disclosing the use of animal-derived constituents in anaesthesia and surgery is warranted under Beauchamp and Childress’ four principles approach to the problem. Although there exist systemic and practical challenges to implementing this in practice, the ethical case for doing so is strong. The Montgomery ruling presents additional legal reason for disclosure because it entails that patients must be made aware of risks associated with their treatment that they attach significance to.

2 January 2022 in The New Bioethics
Verified
Journal Article
Open access
DRDaniel Rodger
Daniel Rodger
BBBruce P. Blackshaw
Bruce P. Blackshaw
A COVID-19 vaccine mandate is being introduced for health and social care workers in England, and those refusing to comply will either be redeployed or have their employment terminated. We argue that COVID-19 vaccination should not be mandatory for these workers for several reasons. First, it ignores their genuine concerns, and fails to respect their moral integrity and bodily autonomy. Second, it risks causing psychological reactance, potentially worsening vaccine hesitancy. Third, Black and minority ethnic workers are less likely to have been vaccinated and therefore may be disproportionately impacted by the implications of the mandate. Fourth, a mandate could have a significant negative effect on service provision. Fifth, waning immunity and new variants mean that booster doses are increasingly likely to be regularly required, meaning that what constitutes being ‘fully vaccinated’ will be a constantly shifting target. Finally, vaccine mandates may have an adverse effect on health and social care recruitment. We argue that daily rapid antigen testing is a viable alternative to a vaccine mandate that is non-coercive and fair. This could also be supplemented by monetary incentives to be vaccinated.

30 October 2020 in Journal of Medical Ethics
Verified
Journal Article
Closed access
PDF file
DRDaniel Rodger
Daniel Rodger
NCNicholas Colgrove
Nicholas Colgrove
BBBruce Philip Blackshaw
Bruce Philip Blackshaw
The rapid development of artificial womb technologies means that we must consider if and when it is permissible to kill the human subject of ectogestation—recently termed a ‘gestateling’ by Elizabeth Chloe Romanis—prior to ‘birth’. We describe the act of deliberately killing the gestateling asgestaticideand argue that there are good reasons to maintain that gestaticide is morally equivalent to infanticide, which we consider to be morally impermissible. First, we argue that gestaticide is harder to justify than abortion, primarily because the gestateling is completely independent of its biological parents. Second, we argue that gestaticide is morally equivalent to infanticide. To demonstrate this, we explain that gestatelings are born in a straightforward sense, which entails that killing them is as morally serious as infanticide. However, to strengthen our overall claim, we also show that if gestatelings are not considered to have been born, killing them is still equivalent to killing neonates with congenital anomalies and disabilities, which again is infanticide. We conclude by considering how our discussion of gestaticide has implications for the permissibility of withdrawing life-sustaining treatment from gestatelings.